Contact Lens Update Diabetic Eye Disease Branded vs Generics Vision Innovation Dry Eye Viewpoint Diabetic Eye Disease Viewpoint Diabetic Eye Disease Podcast Management of Dry Eye Viewpoints Myopia Management

Contact Lens Update Diabetic Eye Disease Branded vs Generics Vision Innovation Dry Eye Viewpoint Diabetic Eye Disease Viewpoint Diabetic Eye Disease Podcast Management of Dry Eye Viewpoints Myopia Management

View More Allergy Cataract Contact Lenses COVID-19 Dry Eye Glaucoma LASIK OCT Refractive Surgery Retina

Allergy Cataract Contact Lenses COVID-19 Dry Eye Glaucoma LASIK OCT Refractive Surgery Retina

Practice Management

All News Practice Management

Expert Interviews

MJH Broadcast Channel

Expert Interviews Podcasts MJH Broadcast Channel Viewpoints Insights

Conference Coverage

Conference Listing

Conference Coverage Conference Listing

Digital Edition

Supplements And Featured Publications

Digital Edition iTech Supplements And Featured Publications

Sponsored Resources

Job Board Partners Sponsored Resources

Print Subscription

eNewsletter Print Subscription

Advertise
About Us
Contact Us
Job Board
Terms & Conditions
Privacy
Do not sell my Information

© 2021 MJH Life Sciences and Optometry Times. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

Contact Lens Update
Diabetic Eye Disease
Branded vs Generics
Vision Innovation
Dry Eye Viewpoint
Diabetic Eye Disease Viewpoint
Diabetic Eye Disease Podcast
Management of Dry Eye Viewpoints
Myopia Management

ClinicalSee All >

Allergy
Cataract
Contact Lenses
COVID-19
Dry Eye
Glaucoma
LASIK
OCT
Refractive Surgery
Retina

Advertise
About Us
Contact Us
Job Board
Terms & Conditions
Privacy
Do not sell my Information

© 2021 MJH Life Sciences^™ and Optometry Times. All rights reserved.

Kristin O. Chapman, MD

home
authors
kristin-o.-chapman,-md

Articles

The dropless future: SLT as a first-line treatment for glaucoma

Article

Drop tolerance, adherence remain challenges for physicians and patients with glaucoma.